SCHEMBL10746514

SCHEMBL10746514

NNC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ CTSS P25774 4/20 0.50
▸ CTSL P07711 3/20 0.50
▸ MME P08473 1/20 0.49
▸ ECE1 P42892 1/20 0.49
▸ CTSK P43235 5/20 0.48
▸ CTSB P07858 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10739937 1.00 SMN1; SMN2 (0.56) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL30914622 0.98 SMN1; SMN2 (0.58) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL10746061 0.90 SMN1; SMN2 (0.57) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL10746056 0.90 SMN1; SMN2 (0.57) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL29437121 0.89 SMN1; SMN2 (0.62) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL30914618 0.88 SMN1; SMN2 (0.55) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL8496964 0.88 SMN1; SMN2 (0.61) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL36611 0.88 SMN1; SMN2 (0.61) SMN1; SMN2CTSSCTSLMMEECE1
Hydroxyamine SCHEMBL9197242 0.87 SMN1; SMN2 (0.60) SMN1; SMN2CTSSCTSLMMEECE1
SCHEMBL12109818 0.87 SMN1; SMN2 (0.54) SMN1; SMN2CTSSCTSLMMEECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711952-A IMMUNOSTIMULATIVE, OR IMMUNOSUPPRESSORY AGENTS SPOFA, SPOJENE PODNIKY PRO ZDRAVOTNICKOUVYROBU (CS) 1987-12-08 — — US disclosed
EP-0232435-A2 Serum thymic factor peptide analogs and a process for the preparation thereof SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) 1987-08-19 — — EP disclosed
Send feedback